Tizanidne Hydrochloride Capsule
Product Images NDC 63629-8871

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tizanidne Hydrochloride (NDC 63629-8871). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl636298871)

This is a description of a medication called Tizanidine Hydrochloride Capsules. Each capsule contains 2.29 mg tizanidine hydrochloride equivalent to 2 mg tizanidine base. The medication should be kept out of reach of children and stored at 25°C (77°F). The medication should be dispensed in a tight container with a child-resistant closure. The medication is not interchangeable with tizanidine tablets or Zanaflex tablets. The NDC for this medication is 63629-8871-1, and it is manufactured by BRP Pharmaceuticals.*

FDA Label Image

Tiz01 (Tiz01)

FDA Label Image

Tiz02 (Tiz02)

FDA Label Image

Tiz03 (Tiz03)

FDA Label Image

Tiz04 (Tiz04)

This text appears to be a chart displaying the Improvement in Ashworth Score over time for a study involving Tizanidine, with the mean dose being 26.8 mg. It also shows the progression through the titration and maintenance phases of the study.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.